AbstractThe aims of this study were to generate chimeric human papillomavirus (HPV)-16 L1 virus-like particles (VLPs) in order to identify immunogenic domains and conformational neutralizing epitopes, and to characterize the regions where a foreign epitope could be introduced. We hypothesized that these regions could be on L1 protein loops since they are exposed on the surface of VLPs. The aims of this study were achieved by mutating HPV-16 L1 proteins. Six amino acids encoding for the epitope 78–83 (DPASRE) of the hepatitis B core (HBc) antigen were introduced within the different loops of the L1 protein at positions 56/57, 140/141, 179/180, 266/267, 283/284 or 352/353. All these chimeric L1 proteins were capable of self-assembly into VLPs...
HPV prophylactic vaccination based on VLPs was implemented 7 years ago and has now shown a high degr...
AbstractWe used human papillomavirus type 16 (HPV-16) particles composed of capsid proteins L1 and L...
AbstractNeutralizing antibody against human papillomavirus (HPV) minor capsid protein L2 can cross-n...
AbstractHuman papillomavirus (HPV) hybrid virus-like particles (VLPs) were prepared using complement...
AbstractA panel of 24 monoclonal antibodies (MAbs) was generated against human papillomavirus (HPV) ...
The aim of this study was to characterize the conformational neutralizing epitopes of the major caps...
AbstractCryo-electron microscopy (cryo-EM) was used to solve the structures of human papillomavirus ...
702FP Times Cited:15 Cited References Count:44Both the Human papillomavirus (HPV) major (L1) and m...
Both the Human papillomavirus (HPV) major (L1) and minor (L2) capsid proteins have been well investi...
AbstractCharacterization of the regions of human papillomaviruses (HPVs) that elicit neutralizing im...
AbstractWe have mapped the binding sites on human papillomavirus (HPV) type 6 for three HPV 6-specif...
The majority of the neutralizing epitopes of papillomaviruses (PV) are conformation-specific and hav...
AbstractWe compared the neutralization abilities of individual monoclonal antibodies (MAb) of two la...
Human papillomavirus type 6 (HPV6) is the major etiologic agent of genital warts and recurrent respi...
Abstract Background Human papillomavirus (HPV) L1 capsid proteins can self-assemble into pentamers (...
HPV prophylactic vaccination based on VLPs was implemented 7 years ago and has now shown a high degr...
AbstractWe used human papillomavirus type 16 (HPV-16) particles composed of capsid proteins L1 and L...
AbstractNeutralizing antibody against human papillomavirus (HPV) minor capsid protein L2 can cross-n...
AbstractHuman papillomavirus (HPV) hybrid virus-like particles (VLPs) were prepared using complement...
AbstractA panel of 24 monoclonal antibodies (MAbs) was generated against human papillomavirus (HPV) ...
The aim of this study was to characterize the conformational neutralizing epitopes of the major caps...
AbstractCryo-electron microscopy (cryo-EM) was used to solve the structures of human papillomavirus ...
702FP Times Cited:15 Cited References Count:44Both the Human papillomavirus (HPV) major (L1) and m...
Both the Human papillomavirus (HPV) major (L1) and minor (L2) capsid proteins have been well investi...
AbstractCharacterization of the regions of human papillomaviruses (HPVs) that elicit neutralizing im...
AbstractWe have mapped the binding sites on human papillomavirus (HPV) type 6 for three HPV 6-specif...
The majority of the neutralizing epitopes of papillomaviruses (PV) are conformation-specific and hav...
AbstractWe compared the neutralization abilities of individual monoclonal antibodies (MAb) of two la...
Human papillomavirus type 6 (HPV6) is the major etiologic agent of genital warts and recurrent respi...
Abstract Background Human papillomavirus (HPV) L1 capsid proteins can self-assemble into pentamers (...
HPV prophylactic vaccination based on VLPs was implemented 7 years ago and has now shown a high degr...
AbstractWe used human papillomavirus type 16 (HPV-16) particles composed of capsid proteins L1 and L...
AbstractNeutralizing antibody against human papillomavirus (HPV) minor capsid protein L2 can cross-n...